June 11, 2025
“OLLIE gives pharmaceutical companies a more honest view of the emotional and behavioral realities that shape adherence, grounded not in assumptions but in patients’ own words.” – Michael Oleksiw, Chief Executive Officer at Pleio
May 22, 2025
Drug Store News features Pleio’s report revealing loneliness as a major barrier in chronic care. With 74% of patients reporting that loneliness negatively affects their physical health, the study highlights the need for peer support to improve outcomes and patient engagement.
May 22, 2025
Medication non-adherence costs the U.S. $500B annually. Pleio’s new AI, OLLIE, identifies emotional barriers through patient conversation analysis, empowering human supporters to intervene with empathy and improve outcomes.
May 7, 2025
Jen Butler, chief commercial officer at Pleio, and Mark Gregory, chief pharmacy officer at Pleio, sat down for an interview with Pharmacy Times at Asembia’s AXS25 Summit. They discussed the critical role of emotional support in specialty pharmacy. Drawing on insights from a recent report, Butler and Gregory highlighted the importance of addressing patient barriers in improving medication adherence.
April 30, 2025
Findings of a new report from Pleio, Loneliness and Health Behaviors: A Missing Link in Chronic Care, highlight emotional disengagement as a largely overlooked clinical risk that compromises chronic care management.
April 29, 2025
AJMC highlights a new report from Pleio that reveals a strong connection between loneliness and chronic illness. The findings show that social isolation worsens physical health, contributes to medication nonadherence, and drives up healthcare costs. The report underscores the urgent need to address loneliness as a serious threat to both mental and physical well-being.
FOR MEDIA INQUIRIES PLEASE EMAIL media@pleio.com.